ASP Isotopes Sees Unusually Large Options Volume (NASDAQ:ASPI)

ASP Isotopes Inc. (NASDAQ:ASPI) was the recipient of some unusual options trading on Friday. Stock traders purchased 57,158 call options on the company. This represents an increase of approximately 249% compared to the average volume of 16,355 call options.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. Canaccord Genuity Group reaffirmed a “buy” rating and set a $11.00 price target on shares of ASP Isotopes in a report on Wednesday, September 17th. Loop Capital set a $15.00 price target on shares of ASP Isotopes in a report on Monday, October 27th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of ASP Isotopes in a research note on Thursday, October 30th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, ASP Isotopes has an average rating of “Hold” and an average price target of $13.00.

Insider Activity at ASP Isotopes

In other news, CEO Paul Elliot Mann sold 81,077 shares of the company’s stock in a transaction on Tuesday, September 9th. The shares were sold at an average price of $8.39, for a total value of $680,236.03. Following the sale, the chief executive officer directly owned 8,084,191 shares of the company’s stock, valued at approximately $67,826,362.49. This represents a 0.99% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Michael Gorley sold 64,000 shares of the business’s stock in a transaction on Tuesday, September 30th. The shares were sold at an average price of $9.75, for a total transaction of $624,000.00. Following the transaction, the director owned 81,360 shares in the company, valued at $793,260. The trade was a 44.03% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 406,199 shares of company stock worth $3,718,977 in the last ninety days. Insiders own 21.40% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in ASPI. Quantbot Technologies LP purchased a new position in shares of ASP Isotopes in the 3rd quarter valued at about $34,000. Ameritas Investment Partners Inc. grew its holdings in ASP Isotopes by 41.2% in the second quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company’s stock valued at $40,000 after purchasing an additional 1,600 shares during the period. BNP Paribas Financial Markets increased its position in shares of ASP Isotopes by 84.9% in the second quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock valued at $41,000 after buying an additional 2,548 shares in the last quarter. Close Asset Management Ltd acquired a new position in shares of ASP Isotopes during the 3rd quarter worth approximately $72,000. Finally, Legal & General Group Plc lifted its position in shares of ASP Isotopes by 30.4% during the 3rd quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock valued at $81,000 after buying an additional 1,953 shares in the last quarter. 16.80% of the stock is currently owned by institutional investors.

ASP Isotopes Price Performance

Shares of ASPI traded up $0.15 during mid-day trading on Friday, reaching $8.15. The stock had a trading volume of 5,008,963 shares, compared to its average volume of 4,285,150. The business has a fifty day moving average of $9.67 and a 200 day moving average of $8.71. ASP Isotopes has a 12 month low of $3.65 and a 12 month high of $14.49. The firm has a market cap of $761.08 million, a price-to-earnings ratio of -6.45 and a beta of 3.28. The company has a debt-to-equity ratio of 3.53, a quick ratio of 14.56 and a current ratio of 14.72.

ASP Isotopes (NASDAQ:ASPI) last posted its earnings results on Thursday, August 14th. The company reported ($1.03) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.92). ASP Isotopes had a negative net margin of 2,181.62% and a negative return on equity of 239.22%. The firm had revenue of $1.20 million for the quarter, compared to the consensus estimate of $1.60 million. Equities analysts predict that ASP Isotopes will post -0.24 EPS for the current year.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.